Loading company…
Neurolightech develops light-based medical devices for therapeutic use.
Neurolightech works on light ablation technology for conditions including malignant tumors and cardiac arrhythmias. Its target customers include hospitals, clinics and healthcare providers. Founded in 2018 and based in Tokyo, Japan, it raised JPY 140 million in Series A funding led by RMD Partners in July 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in